336 related articles for article (PubMed ID: 29456531)
1. First Occurrence of Plasmablastic Lymphoma in Adenosine Deaminase-Deficient Severe Combined Immunodeficiency Disease Patient and Review of the Literature.
Migliavacca M; Assanelli A; Ponzoni M; Pajno R; Barzaghi F; Giglio F; Ferrua F; Frittoli M; Brigida I; Dionisio F; Nicoletti R; Casiraghi M; Roncarolo MG; Doglioni C; Peccatori J; Ciceri F; Cicalese MP; Aiuti A
Front Immunol; 2018; 9():113. PubMed ID: 29456531
[TBL] [Abstract][Full Text] [Related]
2. Cerebral lymphoma in an adenosine deaminase-deficient patient with severe combined immunodeficiency receiving polyethylene glycol-conjugated adenosine deaminase.
Kaufman DA; Hershfield MS; Bocchini JA; Moissidis IJ; Jeroudi M; Bahna SL
Pediatrics; 2005 Dec; 116(6):e876-9. PubMed ID: 16263974
[TBL] [Abstract][Full Text] [Related]
3. How We Manage Adenosine Deaminase-Deficient Severe Combined Immune Deficiency (ADA SCID).
Kohn DB; Gaspar HB
J Clin Immunol; 2017 May; 37(4):351-356. PubMed ID: 28194615
[TBL] [Abstract][Full Text] [Related]
4. A 24-Year Enzyme Replacement Therapy in an Adenosine-deaminase-Deficient Patient.
Tartibi HM; Hershfield MS; Bahna SL
Pediatrics; 2016 Jan; 137(1):. PubMed ID: 26684479
[TBL] [Abstract][Full Text] [Related]
5. ADA Deficiency: Evaluation of the Clinical and Laboratory Features and the Outcome.
Cagdas D; Gur Cetinkaya P; Karaatmaca B; Esenboga S; Tan C; Yılmaz T; Gümüş E; Barış S; Kuşkonmaz B; Ozgur TT; Bali P; Santisteban I; Orhan D; Yüce A; Cetinkaya D; Boztug K; Hershfield M; Sanal O; Tezcan İ
J Clin Immunol; 2018 May; 38(4):484-493. PubMed ID: 29744787
[TBL] [Abstract][Full Text] [Related]
6. Consensus approach for the management of severe combined immune deficiency caused by adenosine deaminase deficiency.
Kohn DB; Hershfield MS; Puck JM; Aiuti A; Blincoe A; Gaspar HB; Notarangelo LD; Grunebaum E
J Allergy Clin Immunol; 2019 Mar; 143(3):852-863. PubMed ID: 30194989
[TBL] [Abstract][Full Text] [Related]
7. Morbidity in an adenosine deaminase-deficient patient during 27 years of enzyme replacement therapy.
Grunebaum E; Reid B; Naqvi A; Hershfield MS; Kim VH; Muller MP; Hicks LK; Lee E; Betschel S; Roifman CM
Clin Immunol; 2020 Feb; 211():108321. PubMed ID: 31812707
[TBL] [Abstract][Full Text] [Related]
8. Long-Term Outcome of Adenosine Deaminase-Deficient Patients-a Single-Center Experience.
Scott O; Kim VH; Reid B; Pham-Huy A; Atkinson AR; Aiuti A; Grunebaum E
J Clin Immunol; 2017 Aug; 37(6):582-591. PubMed ID: 28748310
[TBL] [Abstract][Full Text] [Related]
9. Long-term efficacy of enzyme replacement therapy for adenosine deaminase (ADA)-deficient severe combined immunodeficiency (SCID).
Chan B; Wara D; Bastian J; Hershfield MS; Bohnsack J; Azen CG; Parkman R; Weinberg K; Kohn DB
Clin Immunol; 2005 Nov; 117(2):133-43. PubMed ID: 16112907
[TBL] [Abstract][Full Text] [Related]
10. Effects of enzyme replacement therapy on immune function in ADA deficiency patient.
Nakazawa Y; Kawai T; Uchiyama T; Goto F; Watanabe N; Maekawa T; Ishiguro A; Okuyama T; Otsu M; Yamada M; Hershfield MS; Ariga T; Onodera M
Clin Immunol; 2015 Dec; 161(2):391-3. PubMed ID: 26122173
[No Abstract] [Full Text] [Related]
11. Treatment with Elapegademase Restores Immunity in Infants with Adenosine Deaminase Deficient Severe Combined Immunodeficiency.
Hicks ED; Hall G; Hershfield MS; Tarrant TK; Bali P; Sleasman JW; Buckley RH; Mousallem T
J Clin Immunol; 2024 Apr; 44(5):107. PubMed ID: 38676811
[TBL] [Abstract][Full Text] [Related]
12. Metabolite and thymocyte development defects in ADA-SCID mice receiving enzyme replacement therapy.
Moretti FA; Giardino G; Attenborough TCH; Gkazi AS; Margetts BK; la Marca G; Fairbanks L; Crompton T; Gaspar HB
Sci Rep; 2021 Dec; 11(1):23221. PubMed ID: 34853379
[TBL] [Abstract][Full Text] [Related]
13. Adenosine Deaminase (ADA)-Deficient Severe Combined Immune Deficiency (SCID) in the US Immunodeficiency Network (USIDNet) Registry.
Kuo CY; Garabedian E; Puck J; Cowan MJ; Sullivan KE; Buckley RH; Cunningham-Rundles C; Marsh R; Candotti F; Kohn DB
J Clin Immunol; 2020 Nov; 40(8):1124-1131. PubMed ID: 32880085
[TBL] [Abstract][Full Text] [Related]
14. Adenosine Deaminase (ADA)-Deficient Severe Combined Immune Deficiency (SCID): Molecular Pathogenesis and Clinical Manifestations.
Bradford KL; Moretti FA; Carbonaro-Sarracino DA; Gaspar HB; Kohn DB
J Clin Immunol; 2017 Oct; 37(7):626-637. PubMed ID: 28842866
[TBL] [Abstract][Full Text] [Related]
15. Early Enzyme Replacement Therapy Improves Hearing and Immune Defects in Adenosine Deaminase Deficient-Mice.
Xu X; Negandhi J; Min W; Tsui M; Post M; Harrison RV; Grunebaum E
Front Immunol; 2019; 10():416. PubMed ID: 30918508
[No Abstract] [Full Text] [Related]
16. Pulmonary alveolar proteinosis in patients with adenosine deaminase deficiency.
Grunebaum E; Cutz E; Roifman CM
J Allergy Clin Immunol; 2012 Jun; 129(6):1588-93. PubMed ID: 22409989
[TBL] [Abstract][Full Text] [Related]
17. Hematopoietic Cell Transplantation for Adenosine Deaminase Severe Combined Immunodeficiency-Improved Outcomes in the Modern Era.
Ghimenton E; Flinn A; Lum SH; Leahy TR; Nademi Z; Owens S; Williams E; Flood T; Hambleton S; Slatter M; Gennery AR
J Clin Immunol; 2022 May; 42(4):819-826. PubMed ID: 35288820
[TBL] [Abstract][Full Text] [Related]
18. National experience with adenosine deaminase deficiency related SCID in Polish children.
Dąbrowska-Leonik N; Piątosa B; Słomińska E; Bohynikova N; Bernat-Sitarz K; Bernatowska E; Wolska-Kuśnierz B; Kałwak K; Kołtan S; Dąbrowska A; Goździk J; Ussowicz M; Pac M
Front Immunol; 2022; 13():1058623. PubMed ID: 36685585
[TBL] [Abstract][Full Text] [Related]
19. Clinical efficacy of gene-modified stem cells in adenosine deaminase-deficient immunodeficiency.
Shaw KL; Garabedian E; Mishra S; Barman P; Davila A; Carbonaro D; Shupien S; Silvin C; Geiger S; Nowicki B; Smogorzewska EM; Brown B; Wang X; de Oliveira S; Choi Y; Ikeda A; Terrazas D; Fu PY; Yu A; Fernandez BC; Cooper AR; Engel B; Podsakoff G; Balamurugan A; Anderson S; Muul L; Jagadeesh GJ; Kapoor N; Tse J; Moore TB; Purdy K; Rishi R; Mohan K; Skoda-Smith S; Buchbinder D; Abraham RS; Scharenberg A; Yang OO; Cornetta K; Gjertson D; Hershfield M; Sokolic R; Candotti F; Kohn DB
J Clin Invest; 2017 May; 127(5):1689-1699. PubMed ID: 28346229
[TBL] [Abstract][Full Text] [Related]
20. Management of ADA-Deficient SCID Patient on Adagen During Pregnancy.
Shams M; Kobrynski L
J Clin Immunol; 2019 Nov; 39(8):846-848. PubMed ID: 31620946
[No Abstract] [Full Text] [Related]
[Next] [New Search]
